Contact
Please use this form to send email to PR contact of this press release:
Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA
TO:
Please use this form to send email to PR contact of this press release:
Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA
TO: